Clinical Trial Update: Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Antidepressants Alone [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating cariprazine as an adjunct to antidepressant therapy in adults with major depressive disorder after inadequate response to antidepressan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• cariprazine (cariprazine)

Snippet

Sponsor: AbbVie | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2022-10-25